These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 19633953

  • 1. Changing pattern of age-specific breast cancer incidence in the Swiss canton of Geneva.
    Bouchardy C, Usel M, Verkooijen HM, Fioretta G, Benhamou S, Neyroud-Caspar I, Schaffar R, Vlastos G, Wespi Y, Schäfer P, Rapiti E.
    Breast Cancer Res Treat; 2010 Apr; 120(2):519-23. PubMed ID: 19633953
    [Abstract] [Full Text] [Related]

  • 2. Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations.
    Verkooijen HM, Koot VC, Fioretta G, van der Heiden M, Schipper ME, Rapiti E, Peeters PH, Peterse JL, Bouchardy C.
    Breast Cancer Res Treat; 2008 Feb; 107(3):389-95. PubMed ID: 17431760
    [Abstract] [Full Text] [Related]

  • 3. Remarkable change in age-specific breast cancer incidence in the Swiss canton of Geneva and its possible relation with the use of hormone replacement therapy.
    Bouchardy C, Morabia A, Verkooijen HM, Fioretta G, Wespi Y, Schäfer P.
    BMC Cancer; 2006 Mar 22; 6():78. PubMed ID: 16551373
    [Abstract] [Full Text] [Related]

  • 4. Reduction in hormone replacement therapy use and declining breast cancer incidence in the Belgian province of Limburg.
    Vankrunkelsven P, Kellen E, Lousbergh D, Cloes E, Op de Beeck L, Faes C, Bruckers L, Mertens R, Coebergh JW, Van Leeuwen FE, Buntinx F.
    Breast Cancer Res Treat; 2009 Nov 22; 118(2):425-32. PubMed ID: 19238536
    [Abstract] [Full Text] [Related]

  • 5. Reductions in use of hormone replacement therapy: effects on Swedish breast cancer incidence trends only seen after several years.
    Lambe M, Wigertz A, Holmqvist M, Adolfsson J, Bardage C, Fornander T, Karlsson P, Odlind V, Persson I, Ahlgren J, Bergkvist L.
    Breast Cancer Res Treat; 2010 Jun 22; 121(3):679-83. PubMed ID: 19894110
    [Abstract] [Full Text] [Related]

  • 6. Reduced risk of oestrogen receptor positive breast cancer among peri- and post-menopausal women in Scotland following a striking decrease in use of hormone replacement therapy.
    Sharpe KH, McClements P, Clark DI, Collins J, Springbett A, Brewster DH.
    Eur J Cancer; 2010 Mar 22; 46(5):937-43. PubMed ID: 20122823
    [Abstract] [Full Text] [Related]

  • 7. The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence.
    Verkooijen HM, Bouchardy C, Vinh-Hung V, Rapiti E, Hartman M.
    Maturitas; 2009 Oct 20; 64(2):80-5. PubMed ID: 19709827
    [Abstract] [Full Text] [Related]

  • 8. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
    Jemal A, Ward E, Thun MJ.
    Breast Cancer Res; 2007 Oct 20; 9(3):R28. PubMed ID: 17477859
    [Abstract] [Full Text] [Related]

  • 9. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy.
    Katalinic A, Rawal R.
    Breast Cancer Res Treat; 2008 Feb 20; 107(3):427-30. PubMed ID: 17453336
    [Abstract] [Full Text] [Related]

  • 10. HRT and breast cancer: impact on population risk and incidence.
    Coombs NJ, Taylor R, Wilcken N, Boyages J.
    Eur J Cancer; 2005 Aug 20; 41(12):1775-81. PubMed ID: 16087330
    [Abstract] [Full Text] [Related]

  • 11. Use of HRT and the subsequent risk of cancer.
    Beral V, Banks E, Reeves G, Appleby P.
    J Epidemiol Biostat; 1999 Aug 20; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [Abstract] [Full Text] [Related]

  • 12. Age distribution of breast cancer in Lebanon: increased percentages and age adjusted incidence rates of younger-aged groups at presentation.
    El Saghir NS, Shamseddine AI, Geara F, Bikhazi K, Rahal B, Salem ZM, Taher A, Tawil A, El Khatib Z, Abbas J, Hourani M, Seoud M.
    J Med Liban; 2002 Aug 20; 50(1-2):3-9. PubMed ID: 12841305
    [Abstract] [Full Text] [Related]

  • 13. Hormone replacement therapy and breast cancer risk in California.
    Coombs NJ, Taylor R, Wilcken N, Fiorica J, Boyages J.
    Breast J; 2005 Aug 20; 11(6):410-5. PubMed ID: 16297085
    [Abstract] [Full Text] [Related]

  • 14. [Decline in breast cancer incidence in 2005 and 2006 in France: a paradoxical trend].
    Allemand H, Seradour B, Weill A, Ricordeau P.
    Bull Cancer; 2008 Jan 20; 95(1):11-5. PubMed ID: 18230565
    [Abstract] [Full Text] [Related]

  • 15. Evolution of breast cancer incidence in relation to hormone replacement therapy use in Belgium.
    Antoine C, Ameye L, Moreau M, Paesmans M, Rozenberg S.
    Climacteric; 2011 Aug 20; 14(4):464-71. PubMed ID: 21545271
    [Abstract] [Full Text] [Related]

  • 16. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy).
    Tzingounis V, Cardamakis E, Ginopoulos P, Argiropoulos G.
    Anticancer Res; 1996 Aug 20; 16(6C):3997-4000. PubMed ID: 9042326
    [Abstract] [Full Text] [Related]

  • 17. A population-based cohort study of HRT use and breast cancer in southern Sweden.
    Olsson H, Bladström A, Ingvar C, Möller TR.
    Br J Cancer; 2001 Sep 01; 85(5):674-7. PubMed ID: 11531250
    [Abstract] [Full Text] [Related]

  • 18. Declining incidence of breast cancer after decreased use of hormone-replacement therapy: magnitude and time lags in different countries.
    Zbuk K, Anand SS.
    J Epidemiol Community Health; 2012 Jan 01; 66(1):1-7. PubMed ID: 21875869
    [Abstract] [Full Text] [Related]

  • 19. Disentangling the roles of mammographic screening and HRT in recent breast cancer incidence trends in italy by analyses based on calendar time and time since screening activation.
    Crocetti E, Buzzoni C, Falcini F, Cortesi L, De Lisi V, Ferretti S, Tumino R, Russo A, Paci E.
    Breast J; 2010 Jan 01; 16(4):350-5. PubMed ID: 20443789
    [Abstract] [Full Text] [Related]

  • 20. Risk of breast cancer in post-menopausal women using hormone replacement therapy.
    Ratanawichitrasin A, Reansuwan W, Ratanawichitrasin S, Bhodhisuwan K, Kongpatanakul S.
    J Med Assoc Thai; 2002 May 01; 85(5):583-9. PubMed ID: 12188389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.